simethicone and Heart-Diseases

In a randomized double-blind comparative study involving a total of 50 patients divided into two equal groups, the effects of Enzym-Paractol and placebo on the ultrasonographic representation of internal organs in two planes--pancreatic and paraaortic--were compared. The visualizability was estimated as percentage figures, and revealed an improvement of about 15% for Enzym-Paractol as compared with placebo. With respect to undesired side effects, there was no difference between the two substances.

Topics: Adult; Aged; Aluminum Hydroxide; Biliary Tract Diseases; Clinical Trials as Topic; Dimethylpolysiloxanes; Double-Blind Method; Drug Combinations; Enzymes; Female; Gastrointestinal Diseases; Heart Diseases; Humans; Kidney Diseases; Liver Diseases; Lung Diseases; Magnesium Oxide; Male; Middle Aged; Premedication; Silicones; Simethicone; Ultrasonography